This copy is for your personal non-commercial use only. To order a copy that can be used for a presentation to distribute to your colleagues, clients or customers, please visit http://www.djreprints.com.

https://www.barrons.com/articles/pfizer-arena-pharmaceuticals-acquisition-51639396154

Pfizer has agreed to acquire Arena Pharmaceuticals, a US biotechnology company, for approximately US$6.7 billion.

The US pharmaceutical giant said the acquisition will expand its pipeline of cancer and inflammatory disease drugs.

Arena Pharmaceuticals (stock code: ARNA) shares soared 93% in pre-market trading to $96.45, while Pfizer (PFE) shares rose 1.6%...

Pfizer has agreed to acquire the United States.

An error has occurred, please try again later.

This article has been sent to

Copyright © 2021 Dow Jones Corporation. all rights reserved

This copy is for your personal non-commercial use only. The distribution and use of this material is subject to our subscriber agreement and copyright laws. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.